Home
2604-B15
2604-B15
Certificate of Analysis
NAD+
Third-party analytical verification
Batch No.
2604-B15Purity
98.852%
Released
May 30, 2026
Batch Information
| Batch Number | 2604-B15 |
| Compound | NAD+ |
| Testing Laboratory | Kovera Labs |
| Analysis Method | RP-HPLC |
| Purity | 98.852% |
| Release Date | May 30, 2026 |
PDF Document
| PDF Filename | LyosLabs_NJ500_COA.pdf |
| PDF Uploaded | June 14, 2026 |
| PDF Size | 1.4 MB |
| PDF Status | Uploaded |
Analysis Results
| HPLC Purity | 98.852% |
| Purity Specification | >98% |
| Net Content | 464.90 mg |
| Net Content Specification | ~500 mg |
| Molecular Formula | C21H27N7O14P2 |
| CAS Number | 53-84-9 |
| Identity Confirmation (LC-MS) | NAD+ 500 mg |
| Physical Form | Lyophilized powder |
| Analytical Method | RP-HPLC | C18 | DAD @ 260 nm |
| Report Number | KVR-2026-520F57 |
| Verification Code | WR15LSI |
Research Use Only
This certificate confirms analytical testing results for research-grade material. All products are supplied exclusively for in vitro research and preclinical studies. Not for human consumption or clinical use.